Visual Rehabilitation Training for Stroke
Trial Summary
What is the purpose of this trial?
This research aims to examine changes in plastic potential of the visual system with time from stroke affecting primary visual cortex. We will measure structural and mechanistic aspects of progressive degeneration along the early visual pathways, correlating them with changes in visual performance, and in responsiveness to visual restoration training. This project will advance both scientific knowledge, as well as technical capability and clinical practices for restoring vision and quality of life for people suffering from cortical blindness.
Do I need to stop my current medications for the trial?
The trial excludes participants who are currently using neuroactive medications that would impact training, as determined by the principal investigator. It is likely that you may need to stop certain medications, but this will be assessed on a case-by-case basis.
What data supports the effectiveness of this treatment for visual rehabilitation after stroke?
Research shows that visual rehabilitation training significantly improves visual field defects in stroke patients, with trained areas showing more improvement than untrained areas. This training is effective both in the early and chronic phases after a stroke, and it helps patients regain a larger visual field sooner, enhancing their overall visual function.12345
How does the Visual Rehabilitation Training for Stroke treatment differ from other treatments for visual field defects?
This treatment is unique because it involves targeted visual training in both the blind and intact fields, which can significantly enhance recovery by stimulating brain plasticity. Unlike other treatments that may focus on spontaneous recovery, this approach actively trains the brain to improve visual field defects, even in chronic phases, by using repetitive visual stimulation.12456
Eligibility Criteria
This trial is for US and Canada residents who've had a stroke damaging the primary visual cortex within the last 6 months, leading to reliable vision defects. Participants must be able to undergo MRI scans, speak English fluently, have good enough eyesight (20/40 or better), and can do daily visual training at home.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments of visual sensitivity and structural measurements using various perimetry and imaging techniques
Training
Participants undergo visual restoration training using specialized software in both blind and intact fields
Follow-up
Participants are monitored for changes in visual performance and structural aspects post-training
Treatment Details
Interventions
- Chronic Training in the blind field
- Subacute Training in the blind field
- Subacute Training in the intact field
Chronic Training in the blind field is already approved in United States, European Union for the following indications:
- Cortical Blindness
- Hemianopia
- Quadranopia
- Cortical Blindness
- Visual Field Defects
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
National Eye Institute (NEI)
Collaborator
National Institutes of Health (NIH)
Collaborator